McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
45,000
Employees45,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
45,000
Employees45,000

MCK Key Statistics

Market cap
104.85B
Market cap104.85B
Price-Earnings ratio
26.54
Price-Earnings ratio26.54
Dividend yield
0.35%
Dividend yield0.35%
Average volume
733.24K
Average volume733.24K
High today
$871.00
High today$871.00
Low today
$845.48
Low today$845.48
Open price
$854.41
Open price$854.41
Volume
612.27K
Volume612.27K
52 Week high
$871.00
52 Week high$871.00
52 Week low
$558.13
52 Week low$558.13

Stock Snapshot

The current McKesson(MCK) stock price is $850.99, with a market capitalization of 104.85B. The stock trades at a price-to-earnings (P/E) ratio of 26.54 and offers a dividend yield of 34.6%.

As of 2025-11-21, McKesson(MCK) stock has fluctuated between $845.48 and $871.00. The current price stands at $850.99, placing the stock +0.7% above today's low and -2.3% off the high.

The McKesson(MCK)'s current trading volume is 612.27K, compared to an average daily volume of 733.24K.

During the past year, McKesson(MCK) stock moved between $558.13 at its lowest and $871.00 at its peak.

During the past year, McKesson(MCK) stock moved between $558.13 at its lowest and $871.00 at its peak.

MCK News

Simply Wall St 2d
How Strong Oncology Sales and Raised Guidance Could Shape McKesson’s Investment Narrative

McKesson Corporation recently reported strong second-quarter results, with sales rising to US$103.15 billion and net income reaching US$1.11 billion, driven by...

How Strong Oncology Sales and Raised Guidance Could Shape McKesson’s Investment Narrative

Analyst ratings

79%

of 19 ratings
Buy
78.9%
Hold
15.8%
Sell
5.3%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.